• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本川崎病的累积发病率。

Cumulative incidence of Kawasaki disease in Japan.

作者信息

Nakamura Yosikazu, Yashiro Mayumi, Yamashita Maho, Aoyama Namiko, Otaki Ushio, Ozeki Yukie, Sano Takashi, Kojo Takao, Ae Ryusuke, Aoyama Yasuko, Makino Nobuko, Kotani Kazuhiko

机构信息

Department of Public Health, Jichi Medical University, Shimotsuke, Tochigi, Japan.

出版信息

Pediatr Int. 2018 Jan;60(1):19-22. doi: 10.1111/ped.13450.

DOI:10.1111/ped.13450
PMID:29095541
Abstract

BACKGROUND

Although the incidence rates of Kawasaki disease (KD) in Japan have been determined in nationwide surveys, the cumulative incidence, that is, the proportion of those with a history of KD in the general population of 10-year-olds, is currently unknown. The aim of this study was therefore to assess the cumulative incidence of KD in Japan.

METHODS

Using the age- and sex-specific incidence rate of KD in Japan from the results of the nationwide surveys, incidence probabilities, that is, the age-specific number of KD patients divided by the population used in the vital statistics, and cumulative proportions of those not affected by KD up to the end of 9 years of age, were calculated. The cumulative incidence was then defined as 1 minus the cumulative proportion. The observed age classes were 0, 1, 2, 3, 4, and 5-9 years. All data were calculated by sex.

RESULTS

The cumulative incidence was 0.004833 for boys and 0.003474 for girls in 1991, but was 0.015284 and 0.012145 in 2014, respectively. According to these figures, 15.284 per 1,000 boys and 12.145 per 1,000 girls have been affected by KD by the age of 10 years. The birth-cohort cumulative incidences had similar trends.

CONCLUSIONS

More than 10 persons in 1,000 have a history of KD at age 10 years in Japan.

摘要

背景

尽管日本已通过全国性调查确定了川崎病(KD)的发病率,但目前尚不清楚累积发病率,即10岁普通人群中曾患川崎病者的比例。因此,本研究旨在评估日本川崎病的累积发病率。

方法

利用全国性调查结果中日本川崎病的年龄和性别特异性发病率,计算发病概率,即川崎病患者的年龄特异性数量除以生命统计中使用的人口数,以及截至9岁未患川崎病者的累积比例。然后将累积发病率定义为1减去累积比例。观察的年龄组为0、1、2、3、4岁以及5至9岁。所有数据按性别计算。

结果

1991年男孩的累积发病率为0.004833,女孩为0.003474,但2014年分别为0.015284和0.012145。根据这些数据,到10岁时,每1000名男孩中有15.284人、每1000名女孩中有12.145人曾患川崎病。出生队列累积发病率有相似趋势。

结论

在日本,每1000人中超过10人在10岁时有川崎病病史。

相似文献

1
Cumulative incidence of Kawasaki disease in Japan.日本川崎病的累积发病率。
Pediatr Int. 2018 Jan;60(1):19-22. doi: 10.1111/ped.13450.
2
Epidemiological observations of Kawasaki disease in Japan, 2013-2014.2013 - 2014年日本川崎病的流行病学观察
Pediatr Int. 2018 Jun;60(6):581-587. doi: 10.1111/ped.13544.
3
Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.2015 - 2016年日本川崎病全国流行病学调查
Pediatr Int. 2019 Apr;61(4):397-403. doi: 10.1111/ped.13809. Epub 2019 Apr 16.
4
Cumulative incidence of Kawasaki disease with cardiac sequelae in Japan.日本川崎病合并心脏后遗症的累积发病率。
Pediatr Int. 2020 Apr;62(4):444-450. doi: 10.1111/ped.14164. Epub 2020 Apr 16.
5
Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey.2011 - 2012年日本川崎病的描述性流行病学:来自第22次全国性调查结果
J Epidemiol. 2015;25(3):239-45. doi: 10.2188/jea.JE20140089. Epub 2015 Feb 7.
6
Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992.日本川崎病的流行病学情况:基于1991年和1992年全国发病率调查
Pediatrics. 1995 Apr;95(4):475-9.
7
Temporal and geographical clustering of Kawasaki disease in Japan: 2007-2012.2007 - 2012年日本川崎病的时间和地理聚集性
Pediatr Int. 2016 Nov;58(11):1140-1145. doi: 10.1111/ped.12970. Epub 2016 Jun 21.
8
Nationwide survey on Kawasaki disease in Japan.日本全国川崎病调查。
Pediatrics. 1987 Jul;80(1):58-62.
9
Nationwide surveys show that the incidence of recurrent Kawasaki disease in Japan has hardly changed over the last 30 years.全国性调查显示,在过去30年里,日本川崎病复发的发病率几乎没有变化。
Acta Paediatr. 2017 May;106(5):796-800. doi: 10.1111/apa.13773. Epub 2017 Feb 26.
10
Update of the epidemiology of Kawasaki disease in Japan--from the results of 1993-94 nationwide survey.日本川崎病流行病学的最新情况——基于1993 - 1994年全国调查结果
J Epidemiol. 1996 Sep;6(3):148-57. doi: 10.2188/jea.6.148.

引用本文的文献

1
Fostering Global Collaboration Around Kawasaki Disease. Reflections From the 14th International Kawasaki Disease Symposium.促进全球范围内关于川崎病的合作。来自第14届国际川崎病研讨会的思考。
CJC Pediatr Congenit Heart Dis. 2024 Oct 22;3(6):237-240. doi: 10.1016/j.cjcpc.2024.10.004. eCollection 2024 Dec.
2
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
3
Shining a Light: Ocular Coherence Tomography and the Pathology of Late Convalescent Kawasaki Disease.
照亮前路:光学相干断层扫描与恢复期晚期川崎病的病理学
JACC Adv. 2024 Apr 17;3(6):100938. doi: 10.1016/j.jacadv.2024.100938. eCollection 2024 Jun.
4
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据:美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
5
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.多中心、随机、开放标签、盲终点评估的皮质类固醇加静脉注射免疫球蛋白(IVIG)和阿司匹林与 IVIG 和阿司匹林预防川崎病(KD)冠状动脉瘤(CAA)的试验:KD CAA 预防(KD-CAAP)试验方案。
Trials. 2023 Jan 26;24(1):60. doi: 10.1186/s13063-022-07051-9.
6
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.《心脏病与卒中统计数据-2023 更新:美国心脏协会报告》。
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
7
Should We Be Screening for Ischaemic Heart Disease Earlier in Childhood?我们是否应该在儿童期更早地筛查缺血性心脏病?
Children (Basel). 2022 Jun 30;9(7):982. doi: 10.3390/children9070982.
8
Falling Through the Cracks: The Current Gap in the Health Care Transition of Patients With Kawasaki Disease: A Scientific Statement From the American Heart Association.《从裂隙中坠落:川崎病患者医疗过渡期的当前差距:美国心脏协会的科学声明》
J Am Heart Assoc. 2021 Oct 19;10(20):e023310. doi: 10.1161/JAHA.121.023310. Epub 2021 Oct 11.
9
Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach.通过下一代测序技术鉴定川崎病中的循环 microRNA。
Curr Issues Mol Biol. 2021 Jun 25;43(2):485-500. doi: 10.3390/cimb43020037.
10
Pathophysiology and therapy of systemic vasculitides.系统性血管炎的病理生理学与治疗
EXCLI J. 2020 Jun 18;19:817-854. doi: 10.17179/excli2020-1512. eCollection 2020.